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Abstract
The novel ion-pair ([TPB]- [DH]+) of the quaternary ammonium drug desipramine hydrochloride, 3-(5,6-
dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine, has been synthesized and incorporated 
into a poly(vinyl chloride)-based membrane sensor for the quantification of desipramine hydrochloride in 
different pharmaceutical preparations. The influence of the membrane composition on the potentiometric 
responses of the membrane sensor has been found to substantially improve the performance 
characteristics. The best performance was reported with membranes having the composition (in mg) of 
([TPB]- [DH]+) (5): PVC (150): o-NPOE (150). The proposed sensor (sensor no. 4) exhibits a nernstian 
response in the concentration range of 2.2 × 10-6 – 1.0 × 10-2 M with a detection limit of 1.2 × 10-6 M. The 
membrane sensor performs satisfactorily over the pH range of 2.8 – 7.4 with a fast response time of 12 
seconds. The sensor no. 4 can tolerate a non-aqueous content of up to 20% and can be utilized for the 
determination of drug concentration in pharmaceutical preparation (tablets) and in body fluids such as 
urine and blood samples. The results were comparatively evaluated with Liquid Chromatography (LC). It 
was observed that the concentration of drug was greater in the blood sample than in the urine sample, as 
most of the drug is metabolized in the liver before discharge to urine. 
Keywords: Quaternary ammonium drug, Desipramine Hydrochloride, Poly(vinyl chloride) membrane 
sensor,
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1. Introduction
Desipramine hydrochloride, 3-(5,6-dihydrobenzo[b][1] benzazepin-11-yl)-N-methylpropan-1-
amine, a tertiary amine tricyclic antidepressant, is structurally related to both the skeletal muscle 
relaxant cyclobenzaprine and the thioxanthene antipsychotics such as thiothixene. Desipramine 
is used to treat depression, pain of neuropathic origin, attention deficit hyperactivity disorder, 
functional enuresis in children, panic and phobic disorder and to manage some eating disorders 
[1-3]. Desipramine inhibits the re-uptake of noradrenalin at the noradrenergic nerve endings and 
the re-uptake of serotonin (5-hydroxytryptamine) at the serotoninergic nerve endings in the 
central nervous system. These two effects are considered to be the likely basis of the 
antidepressant effect of desipramine. The drug also has a strong anticholinergic effect and serves 
as an antagonist on a1 and H1 receptors. Therefore, its quantification is necessary in different 
biological samples and bulk formulations, as well as in different finished product dosages forms 
such as tablets, capsules, injections, etc. Several analytical methods have been reported as 
generic methods for most antidepressants or exclusively for the quantitative determination of 
desipramine hydrochloride (DH) and its metabolites in biological samples using capillary 
electrophoresis, Gas Chromatography, Liquid Chromatography, UV and mass spec detection [4–
15]. All of these methods require time-consuming and costly sample pretreatment. 
Thus, there is critical need for the development of selective, portable, inexpensive diagnostic 
tools for the determination of this analyte. Analytical methods based on potentiometric detection 
with ion-selective electrodes (ISEs) can be considered as an advantageous alternative because 
they are eco-friendly techniques, provide easy construction and manipulation, present good 
selectivity in a wide concentration range, a relatively low detection limit, show fast response and 
perform non-destructive analysis. This has led to increasing interest by our research group in the 
development and application of an ion-selective electrode using various cyclic and acyclic 
neutrals and ion-pairs for the determination of metal [16-21] and non-metal ions [22-23], organic 
molecules [24] and some selective drugs [25-32]. With this intent, we synthesized an NaTPB-
based ion pair of desipramine hydrochloride [TPB]- [DH]+ and used it as a carrier molecule in a 
PVC-based membrane sensor for the determination of desipramine hydrochloride in biological 
samples and in different drug formulations.
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2. Experimental
2.1. Reagents and materials
High molecular weight polyvinyl chloride (PVC) and desipramine hydrochloride were obtained 
from Aldrich (Wisconsin, USA); o-nitrophenyl octyl ether (o-NPOE) and potassium tetrakis(4-
chlorophenyl borate) (KTpClPB), from Fluka (Ronkonkoma, NY); tri-n-butylphosphate (TBP), 
from BDH (Poole, England); chloronapthalene (CN), dibutylphthalate (DBP), sodium 
tetraphenylborate (NaTPB) and dibutyl(butyl) phosphonate (DBBP), from Mobile (Alabama, 
USA); drug standard, from CDL (Central Drug Laboratory, Calcutta, India).
2.2 Preparation of ion-pair complex
The ion pair [TPB]-[DH]+ has been synthesized by separately preparing equimolar solutions (1.0 
× 10-3 M) of NaTPB and desipramine hydrochloride (DH), each in 50 mL of ethanol, in round-
bottom flasks, dissolved by moderate heating with a magnetic stirrer. Subsequently, small 
aliquots of dissolved DH filled by burette were added to the round-bottom flask of NaTPB with a 
magnetic stirrer at 78oC. When all of the content was added, the mixture was retained with 
magnetic stirring for 30 minutes for complete mixing, followed by refluxing for 2 hours over 
CaCl2 to remove the moisture, and storing overnight. In the morning, light yellowish-white 
precipitate was observed. The precipitate was filtered, washed with small aliquots of ethanol and 
recrystallized with ethanol.
[TPB]- [DH]+. Yield: 68%; color: yellowish-white; U.V-vis (max/nm) (0.005% w/v methanol):
251, 255. Elemental analysis (by %) was observed: C = 86.05, B = 1.72, N = 4.71, H = 7.06, and 
calculated % was C = 86.09, B = 1.80, N = 4.76, H = 7.16. The observed elemental analysis is 
consistent with the theoretical data obtained on the basis of the structure as given in Figure 1. 
2.3. Stoichiometry of [TPB]- [DH]+
The discussion of stoichiometry of ion-pair [TPB]- [DH]+ was necessary to prove the association 
of ionic species performed using Job’s method. The concentrations of desipramine hydrochloride 
(DH) and NaTPB were taken to be constant (1.5 × 10-3 M). Nine methanolic solutions were 
prepared containing desipramine hydrochloride and NaTPB in various molar ratios so that the 
final volume always amounted to 10 mL after the addition of phosphate buffer (0.04 M) pH 5.5. 
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The extraction was performed using 10 mL of chloroform, and the absorbance was measured at 
251 nm. The plot reached a maximum value at mole fraction Xmax = 0.5 (Figure 2), which 
indicates the formation of 1:1 ion-pair association.
2.4. Electrode fabrication
The PVC-based membranes were prepared by dissolving appropriate amounts of ion pair [TPB]-
[DH]+, solvent mediators dioctyl phthalate (DOP), tri-n-butylphosphate (TBP), 1-
chloronaphthalene (CN) and o-nitrophenyl octyl ether (o-NPOE) and appropriate amounts of 
PVC in THF (5-10 mL). After complete dissolution of all components and thorough mixing, the 
resulting mixture was poured into polyacrylate rings placed on a smooth glass plate. THF was 
allowed to evaporate for about 24 h at 25 oC. To obtain membranes with reproducible 
characteristics, the viscosity of the solution and solvent evaporation were carefully controlled; 
otherwise, morphology and thickness of the membranes have shown drastic variations that 
ultimately affected the sensor response. The transparent membranes of 0.4 mm thickness were 
carefully removed from the glass plate. A 5 mm diameter piece was cut out and glued to one end 
of a Pyrex glass tube. The membranes thus prepared were equilibrated for 2-3 days in a standard 
drug solution of 1.0 × 10-2 M. Membranes of different compositions were prepared and 
investigated. Ones that gave reproducible results and best performance characteristics were 
selected for detailed studies. The optimum composition of membranes for best performance is 
given in Table 1. It was reported that sensor no. 4 shows the best performance in terms of 
detection limit (1.2 × 10-6 M), working range (2.2 × 10-6 – 1.0 × 10-2 M), slope (59.2 mV/decade 
of activity) and response time (12 s).
2.5. Conditioning of membranes and potential measurements
The membrane electrode bodies containing an inner solution of 1.0 × 10-1 M prepared as above 
were equilibrated for 2-3 days in a standard drug solution of 1.0 × 10-2 M using phosphate buffer 
(0.04 M) pH 5.5 prior to potential measurements. The potential measurements were carried out at 
25±1oC using a saturated calomel electrode (SCE) as the reference electrode with the following 
cell assembly: Hg/Hg2Cl2|KCl (satd.)|0.1M DH||PVC membrane||test solution|Hg/Hg2Cl2|KCl 
(satd.)
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3. Results and Discussion
3.1. Calibration of electrode
Calibration of the sensor’s detection parameters such as the detection limit and the working 
range was performed by response to the standard drug solution. The membrane holder assembly 
was immersed in 1.0 × 10-2 M  standard drug solution, the inner compartment filled with 1.0 × 
10-1 M solution for 2 days, and potentiometric responses were reported for 1.0 × 10-7 – 1.0 × 10-2
M standard drug dilutions in phosphate buffer (0.04 M) pH = 5.5 for comparative analysis of real 
samples. The results are plotted in Figure 3. For the standard drug solution, sensor no. 4 shows a 
detection limit of 1.0 × 10-6 M and a working range of 2.0 × 10-6 – 1.0 × 10-2 M.
3.2. Selectivity coefficient
The selectivity of the membrane sensor is one of the most important performance parameters that 
determine the utility of the sensor. Thus, selectivity studies were carried out only for sensor no. 
4, which exhibited the best performance characteristics in terms of working concentration range, 
slope, response time and lifetime. The selectivity coefficients ( ) were determined by the 
modified form of fixed interference method (FIM), as represented by equation no. 1 suggested by 
Saez de Viteri and Diamond [33], and are given in Table 2. Thus, sensor no. 4 is highly selective 
to DH+ ions above all of the interfering ions and organic molecules studied and listed in Table 2. 
Thus, the selectivity coefficient indicates that it is possible to determine DH+ concentration. It is 
important to note that the concentration of interfering ions that the sensor can tolerate for levels 
of DH+ below or slightly above that of the interfering ion depends on the numerical value of the 
selectivity coefficient. Smaller values of the selectivity coefficient indicate higher tolerance for 
concentration of interfering ion(s) by the sensor. To have a practical idea of the concentration 
level that can be tolerated, mixed run studies were carried out in the presence of different 
concentrations of Imipramine HCl (IH), which showed higher values of selectivity coefficient for 
proposed sensor no. 4. In this measurement, the potential of the sensor was determined as a 
function of DH+ concentration at various IH+ concentrations, and the results are shown in Figure 
4. The linear portion of the plot is the reduced working concentration range that can tolerate the 
IH+ concentration causing deviation. Cell potential varies with activity of DH+ at different 
concentration levels of IH+ ions (sensor no. 4). 1.0 × 10−5 M is tolerated over the entire working 
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concentration range (2.2 × 10−6 to 1.0 × 10−2 M), as it causes no deviation. However, IH+
concentrations of 1.0 × 10−4, 1.0 × 10−3 and 1.0 × 10−2 M cause deviation in the pure solution 
plot of DH+. Thus, these results show that the sensor can be used to determine DH+ even in the 
presence of IH+ at concentrations several times that of DH+. The performance of the sensor with 
regard to the interference effect of other ions is better still because their selectivity coefficient 
values are smaller than that for IH+.
                                                             (1)
3.3. Effect of pH
The effect of pH on the performance of the most responsive membrane sensor, no. 4, was studied 
over the pH range of 2 to 8 using two concentrations, 1.0 × 10-4 M and 1.0 × 10-3 M of DH+. The 
pH was adjusted by using dilute nitric acid and sodium hydroxide. The potential of the proposed 
sensor was determined as a function of pH, and the results are shown in Figure 5. The potential 
remains constant over the pH range of 2.8-7.4, which may be taken as the working pH range of 
the sensor assembly. 
3.4. Non-aqueous effect
The performance of sensor no. 4 was further assessed in partial non-aqueous media, i.e., 
methanol-water, ethanol-water and acetonitrile-water mixtures. The results are compiled in Table 
3 and show that no significant change occurs in the slope and working concentration of the 
sensor at up to 20% non-aqueous content. However, above 20% non-aqueous content, the 
working concentration of the sensor is significantly reduced; thus, the sensor can only be utilized 
in mixtures of up to 20% non-aqueous content.
3.5. Effect of plasticizers
It is well known that the sensitivity and selectivity of a cation-selective sensor strongly depend 
on the membrane composition and the nature of the plasticizer used [34,35]. The effect of 
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plasticizer on DH+ selective membrane sensor no. 4 is shown in Table 4. It is clear from the 
corresponding table that o-NPOE is a more effective plasticizer than others in preparing the DH+
selective membrane sensor. It is noteworthy that the lipophilicity of plasticizer influences both 
the dielectric constant of the polymeric membranes and the mobility of the ionophore and its 
metal complex [36,37]. This indicates that o-NPOE plasticizes the membrane, dissolves the ion 
association complexes and adjusts both the permittivity and the ion exchanger site mobility to 
give highest possible selectivity and sensitivity.4. Analytical Application
4.1 Application to pharmaceutical preparations
The proposed sensor number 4 has been applied for analysis of a commercial tablet of 
desipramine hydrochloride (50 mg) by using the standard addition method [38]. In the standard 
addition method, known small increments of a 1.0 × 10-2 M standard drug solution were added to 
50.0 mL aliquots of various concentrations (1.0 × 10-6 – 1.0 × 10-2 M) of pharmaceutical 
preparations (tablet). The changes in potential were recorded for each increment and were used 
to calculate the concentration of the drug sample solution using the following equation:
                                                             (2)
where Cx and Vx are the concentration and volume of the unknown sample, respectively, Cs and 
Vs are the concentration and volume of the standard, respectively, S is the slope of the calibration 
graph, and ΔE is the change in potential due to the addition of standards. The results are 
summarized in Table 5. During analysis, it was observed that sensor no. 4 work well in 
pharmaceutical preparation measurements.
4.2 Determination of desipramine hydrochloride in blood and urine samples
The proposed sensor number 4 has been applied for the determination of desipramine 
hydrochloride in blood and urine samples, and results were comparatively evaluated with LC. 
Seven volunteers (depression patients) selected for the study had taken 50 mg doses of 
desipramine HCl drug, and their blood and urine samples were collected at different time 
intervals. The complete arrangement was done under the supervision of doctors in a nearby city 
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hospital. The samples of urine and blood were separately centrifuged at 8000 rpm to remove the 
blood cells and other dead cells. Finally, 1 mL of each sample (urine & blood) was diluted using 
phosphate buffer (pH 6.5, 0.03 M) to 10 mL. The proposed sensor (no. 4) was directly used to 
measure the potential and to evaluate the drug concentration present in both samples (blood & 
urine) by using a calibration graph (Graph 3). The chromatographic separation was optimized in 
the YMC Pack Pro C18 column (150 × 4.6 mm and 3.0 µm as particle size). The gradient LC 
method uses water: trifluoroacetic acid in the ratio of 100 : 0.05 (v/v) as mobile phase A and 
acetonitrile: trifluoroacetic acid in the ratio of 100 : 0.08 (v/v) as mobile phase B. The flow rate 
of the mobile phase was 1.0 mL min-1. The LC gradient program was set as (time/% mobile 
phase B): 0/15, 30/70 and 45/70 with a post-run time of 5 min. The column temperature was 
maintained at 40 oC, and the detection was set at a wavelength of 215 nm. The column loading 
was optimized as 6 µg of desipramine hydrochloride in 10 µL injection volume. A mixture of 
water and acetonitrile was used as a diluent in a 1:1 ratio. The results are presented in Table 6. 
The values obtained from the sensor are slightly higher in comparison to LC, which may be 
accounted for by the ISE uncertainty, since the Nernst relation is a log-linear one, enabling even 
small errors in the slope of a calibration curve to translate to relatively large absolute errors. 
However, it may be concluded that the proposed sensor is quite sensitive and can be used for the 
determination of drug concentrations in biological fluids. The estimated drug concentration is 
higher in blood samples in comparison to urine samples, as some part of the drug is metabolized, 
and excess drug is excreted in urine. As the active drug concentration is many times higher than 
that reported in Table 6, our proposed work has many applications to measure the drug 
concentration from the lowest level to a higher level, the latter also being a measure of toxicity.      
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Figure captions
1.  Structure of ion-pair [TPB]- [DH]+
2. Stoichiometry of ion-pair [TPB]- [DH]+, Xmax = 0.5, phosphate buffer (0.04 M).
3. Calibration curve in response to the standard drug solution at pH 5.5 (phosphate buffer, 0.04 
M  ), Detection limit 1.0 × 10-6 M,  working range 2.0 × 10-6 – 1.0 × 10-2 M.
4. Interference study of Imipramine hydrochloride (IH+) in detection of desipramine 
hydrochloride (DH+) by sensor no. 4.
5.  Effect of pH on the response of proposed sensor no. 4. (pH range 2.8-7.4). 
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Table 1.  Optimization of membranes by varying the composition of ingredients. 
*SD, Standard deviation for three consecutive measurements.
Composition of membranes (w/w), mgSensor
no.
[TPB]-
[DH]+
PVC DOP CN o-NPOE DBBP
Working concentration 
range (M)
Detection limit 
(M)  ± *SD
Slope 
mV/decade of 
activity ± *SD
Response 
Time (s)
1 5 150 - - - - 2.1 × 10-4 – 1.0 × 10-2 1.8 × 10-4  ± 0.04 42.5 ±  0.05 23
2 5 150 150 - - - 3.3 × 10-5 – 1.0 × 10-2 2.8 × 10-5 ±  0.06 55.6 ±  0.04 17
3 5 150 - 150 - - 1.3 × 10-5 – 1.0 × 10-2 1.0 × 10-5 ±  0.05 57.5 ±  0.06 14
4 5 150 - - 150 - 2.2 × 10-6 – 1.0 × 10-2 1.2 × 10-6 ±  0.03 59.2 ±  0.06 12
5 5 150 - - - 150 6.3 × 10-5 – 1.0 × 10-2 5.9 × 10-5 ±  0.06 54.4 ±  0.03 18
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Table 2. Selectivity coefficient ( ) values reported against the most responsive membrane 
sensor (Sensor no. 4).
                 
*Quaternary ammonium drug salts
**Metabolite of desipramine hydrochloride
Interfering ion (X) Selectivity coefficient ( )
CH3COO
- 1.3 × 10-4
SCN- 1.2 × 10-3
*Neostigmine(+) 2.3 × 10-2
*Propantheline(+) 2.1 × 10-2
*Lofepramine (+) 1.8 × 10-2
NH4
+ 2.3 × 10-3
*Imipramine(+) 3.5 × 10-1
Na+ 1.4  × 10-4
Ca2+ 2.1 × 10-3
Ba2+ 2.5 × 10-3
**2-hydroxydesipramine(+) 4.5 × 10-2
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Table 3. Non-aqueous effect on the performance of the most responsive membrane sensor
Non–aqueous content (%v/v) Working concentration range (M) Slope (± 0.2 mV decade-1 of 
activity)
0 2.2 × 10-6 - 1.0 × 10-2 59.2
Methanol
10 2.2 × 10-6 - 1.0 × 10-2 59.2
15 2.2 × 10-6 - 1.0 × 10-2 59.2
20 2.3 × 10-6 - 1.0 × 10-2 59.1
25 4.8 × 10-6  -  1.0 × 10-2 58.1
30 8.4 × 10-5  -  1.0 × 10-2 57.5
Ethanol
10 2.2 × 10-6 - 1.0 × 10-2 59.2
15 2.1 × 10-6 - 1.0 × 10-2 59.2
20 2.2 × 10-6 - 1.0 × 10-2 59.3
25 5.2 × 10-6 - 1.0 × 10-2 58.6
30 8.2 × 10-5 - 1.0 × 10-2 57.8
Acetonitrile
10 2.2 × 10-6 - 1.0 × 10-2 59.2
15 2.2 × 10-6 - 1.0 × 10-2 59.2
20 2.1 × 10-6 - 1.0 × 10-2 59.1
25 4.6 × 10-6 - 1.0 × 10-2 58.3
30 8.5 × 10-5 - 1.0 × 10-2 57.2
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Table 4. The effect of plasticizers on the performance of sensor no. 4
*The % (w/w) of total composition of each plasticizer in sensor no. 4
**SD, Standard deviation for three consecutive measurements.
Plasticizer *(%) Working rage (M) Detection limit 
(M) ± **S.D
Slope(mV/decade 
of activity) ± **S.D
Response 
time (s)
DOP (40%)
DOP (45%)
DOP (49%)
DOP (50%)
6.5 × 10-5 – 1.0× 10-2
4.7 × 10-5 – 1.0× 10-2
3.3 × 10-5 – 1.0× 10-2
4.2 × 10-5 – 1.0× 10-2
5.5 × 10-5 ± 0.07 
4.3 × 10-5± 0.05
2.8 × 10-5± 0.06
3.5 × 10-5± 0.05
53.6 ± 0.05
54.4 ± 0.06
55.6 ± 0.04
54.6 ± 0.04
18
17
17
19
CN (40%)
CN (45%)
CN (49%)
CN (50%)
3.5 × 10-5 – 1.0 × 10-2
2.5 × 10-5 – 1.0 × 10-2
1.3 × 10-5 – 1.0 × 10-2
1.8 × 10-5 – 1.0 × 10-2
2.8 × 10-5 ± 0.06
1.9 × 10-5 ± 0.05
1.0 × 10-5 ± 0.05
1.4 × 10-5 ± 0.05
55.5 ± 0.05
56.4 ± 0.06
57.5 ± 0.06
56.3 ± 0.04
15
14
14
15
DBBP (40%)
DBBP (45%)
DBBP (49%)
DBBP (50%)
7.4 × 10-5 – 1.0 × 10-2
6.8 × 10-5 – 1.0 × 10-2
6.3 × 10-5 – 1.0 × 10-2
6.6 × 10-5 – 1.0 × 10-2
6.9 × 10-5 ± 0.07
6.4 × 10-5 ± 0.06
5.9 × 10-5 ± 0.06
6.1 × 10-5 ± 0.04
52.4 ± 0.05
53.8 ± 0.04
54.4 ± 0.03
53.9 ± 0.05
19
18
18
21
o-NPOE (40%)
o-NPOE (45%)
o-NPOE (49%)
o-NPOE (50%)
2.6 × 10-6 – 1.0 × 10-2
2.4 × 10-6 – 1.0 × 10-2
2.2 × 10-6 – 1.0 × 10-2
2.5 × 10-6 – 1.0 × 10-2
1.9 × 10-6 ±  0.03
1.4 × 10-6 ±  0.03
1.2 × 10-6 ±  0.03
1.5 × 10-6 ±  0.03
58.2 ±  0.07
58.9 ±  0.06
59.2 ±  0.06
58.6 ±  0.05
13
12
12
14
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Table 5. Determination of desipramine hydrochloride using sensor No. 4 in pharmaceutical 
preparation.
  
                                
             
         *Average of five measurements
Drug             µg/50 mL-1 (Aqueous)
Taken % Found ± SD* RSD (%)
Desipramine 
hydrochloride 
(50 mg)
10
20
30
40
9.92 ± 0.06
19.91 ± 0.04
29.89 ± 0.06
39.86 ± 0.05
0.60
0.45
0.23
0.25
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Table 6. The comparative evaluation of results with LC.
*Subjects had a mean ± SD age of 31.5±10.8 years
**YMC Pack Pro C18 column (150 × 4.6 mm and 3.0 µm particle size) 
***The urine sample has a lower availability of desipramine hydrochloride, as it is maximally 
metabolized.
Proposed Sensor No. 4 (gm/mL)              LC** (gm/mL)Serial No. Time (h)*
Blood plasma ± SD ***Urine ± SD Blood plasma ± SD ***Urine ± SD
1 6 5.4 × 10-6 ±  0.43 5.2 × 10-6 ±  0.44 4.7 × 10-6 ±  0.63 3.8 × 10-6 ±  0.52
2 8 4.4 × 10-6 ±  0.62 4.1 × 10-6 ±  0.53 4.4 × 10-6 ±  0.54 3.3 × 10-6 ±  0.54
3 10 3.8 × 10-6 ±  0.33 3.4 × 10-6 ±  0.46 4.0 × 10-6 ±  0.48 3.0 × 10-6 ±  0.62
4 12 3.1 × 10-6 ±  0.42 2.8 × 10-6 ±  0.51 3.8 × 10-6 ±  0.45 2.6 × 10-7 ±  0.44
5 14 2.7 × 10-6 ±  0.52 2.4 × 10-6 ±  0.46 3.4 × 10-6 ±  0.62 2.3 × 10-6 ±  0.62
6 16 2.3 × 10-6 ±  0.47 1.8 × 10-6 ±  0.52 3.0 × 10-6 ±  0.52 2.0 × 10-6 ±  0.67
7 18 1.6 × 10-6 ±  0.51 1.2 × 10-6 ±  0.42 2.4 × 10-6 ±  0.44 1.4 × 10-6 ±  0.41
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Figure 5. 
